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The mechanism by which the cell responds to invading pathogens is an area of intense research. Joubert
et al. (2009) have found that the phagocytic receptor CD46 is able to activate autophagy through a tripartite
interaction between itself, a scaffold protein GOPC, and the autophagy inducer complex of Beclin1-VPS34.Macroautophagy (hereafter referred to as
autophagy) was initially characterized as
a general lysosome-dependent pathway
by which cytoplasmic components are
recycled in response to stress and starva-
tion (Xie and Klionsky, 2007). More
recently, this degradative pathway has
been found to be involved in awide variety
of processes, including innate and adap-
tive immune responses to pathogens,
promoting both cell survival and antigen
presentation (Virgin and Levine, 2009).
Autophagy has been found to selectively
target cytosolic or membrane-bound
pathogens, including a variety of bacteria,
parasites, and viruses (Virgin and Levine,
2009). The mechanism by which autoph-
agy is specifically activated for targeted
degradation of pathogens remains to be
fully elucidated.
Recent work has suggested that Toll-
like receptors (TLRs) activate autophagy
in response to binding by their respective
pathogen-associated molecular patterns
(PAMPs) (Sanjuan et al., 2007; Xu et al.,
2007). Members of the Nod-like receptor
family (NLRs) may also target pathogens
to the autophagy pathway (Yano et al.,
2008). However, the mechanism by which
these receptors induce autophagy is not
clear.
CD46 is a broadly expressed C3b- and
C4b-binding protein, the activation of
which can trigger downstream signaling
events, includingVav,Rac, andErk activa-
tion. At its C terminus, CD46 can have one
of two signaling motif-containing tails:
Cyt1 or Cyt2. CD46 has been shown to
be constitutively internalized via clathrin-
coatedpits and is internalized bymacropi-
nocytosis upon antibody-mediated cross-linking (Liszewski et al., 2005). CD46 has
been identified as the receptor for a group
of pathogens that includes viruses and
bacteria. Pathogen/CD46 interaction has
been shown to result in modulation of
CD46 complement regulatory activities,
downstream signaling ability, and the
internalization of the binding pathogen
(Riley-Vargas et al., 2004).
In this issue of Cell Host & Microbe,
Joubert et al. (2009) identify and charac-
terize a pathway through which CD46 is
able to induce autophagy in response to
pathogen binding. They initially observed
that antibody-driven crosslinking of CD46
was sufficient to induce autophagy in
a manner requiring the key autophagy
components Atg5 and Atg7. Induction
of autophagy was also found to be sensi-
tive to the autophagy inhibitor 3-methyla-
denine (a PI3-kinase inhibitor). This auto-
phagic induction was not due to any
secondary effects on autophagosome
maturation but was rather due to de
novo formation of these structures.
How does CD46 initiate autophagy?
Using a yeast two-hybrid screen, Joubert
et al. found that the CD46-Cyt1 isoform
interacts with the class I PDZ domain of
the scaffold protein GOPC. Of interest, a
murine neuron-specific isoform of GOPC
had been previously shown to interact
with Beclin 1, a key component of the
core autophagic machinery (Yue et al.,
2002). Coaffinity purification showed that
this interaction also occurs in human cells
and that the interaction requires GOPC’s
coiled-coil (CC) domain. Beclin 1 is itself
also a scaffold protein that interacts with
VPS34 to form a complex that is required
for autophagy (Xie and Klionsky, 2007).Cell Host & Microbe 6With an siRNA strategy, Joubert et al.
found that starvation-induced autophagy
was not affected in cells treated with
siRNA against CD46-Cyt1 or GOPC,
indicating that these factors are not
components of the general autophagic
machinery.
Different pathogens, including measles
virus (MeV) and certain serotypes of
group A Streptococcus (GAS), have
been found to bind CD46 (Liszewski
et al., 2005). Joubert et al. found that the
Edmonston strain of MeV and emm6+
GAS were both able to induce autophagy
in a CD46-Cyt1- and GOPC-dependent
manner. Of interest, the authors also
looked at the autophagic targeting of
a non-CD46-binding strain of GAS
(emm49+) and observed a significant
delay in degradation of the bacteria,
indicating that CD46 binding is an early
signal to specifically target the bacteria
for degradation by autophagy.
Joubert et al. have shown that the
phagocytic receptor CD46 interacts with
Beclin1-VPS34 via GOPC and that this
interaction is required for the autophagic
response to GAS and MeV binding.
Whether this has an impact on other path-
ogens that are internalized through CD46
binding remains to be determined. Addi-
tionally, this work suggests the possibility
of a wider role for GOPC wherein it could
potentially interact with other cell surface
proteins to induce autophagy. Of interest,
the cystic fibrosis transmembrane con-
ductance regulator CFTR has been
shown to be targeted for lysosomal deg-
radation when bound to GOPC, a process
that likely involves autophagy (Cheng
et al., 2004)., October 22, 2009 ª2009 Elsevier Inc. 297
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following activation of the
CD46-Cyt1/GOPC/Beclin1-
VPS34 pathway remain to
be fully determined. Does
recruitment of Beclin1-VPS34
by GOPC induce production
of PI3P by this complex? If
so, is this sufficient to induce
autophagy, or are other con-
comitant factors (presumably
CD46 receptor dependent)
required for this process? Is
the induction of autophagy
general (i.e., throughout the
cell) (Figure 1, pathway 2) or
targeted predominantly to the
pathogen-containing phago-
some (Figure 1, pathway 1)?
General induction of autoph-
agy by CD46-Cyt1/GOPC/
Beclin1-VPS34 can, upon
receptor crosslinking with
antibody, result in a pool of
preformed autophagosomes, as demon-
strated by Joubert et al. The authors
suggest that this pool can then sequester
and degrade internalized pathogens by an
as yet undetermined mechanism. On the
other hand, targeted induction of autoph-
agy could occur at the phagosomal
membrane itself via recruitment of au-
tophagy factors in a Beclin1-VPS34-
dependent manner. In fact, phagosomes
have been previously found to recruit au-
tophagy components, including Beclin1
and Atg5/12, targeting them to lysosomes
(Huang et al., 2009; Sanjuan et al., 2007).
Some pathogens exploit autophagy in
host cells, so it will be intriguing to see
whether the CD46-Cyt1/GOPC/Beclin1-
VPS34 pathway can serve as both a
host defense and an ‘‘Achilles heel’’ for
different pathogens (Virgin and Levine,
2009).
The mechanism by which cells detect
and specifically identify targets for degra-
dation by selective autophagy remains to
be fully determined, but the characteriza-
tion of this pathway by Joubert et al.
provides important evidence for a recep-
tor used for pathogen internalization that
directly links with known autophagy
components. Whether other CD46-inter-
acting pathogens or GOPC-interacting
membrane proteins induce autophagy in
a similar manner remains to be deter-
mined.
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Figure 1. Model of Cellular Pathways for CD46-Mediated Induction
of Autophagy
(Pathway 1) Autophagy targeted to the pathogen-containing phagosome.
(Pathway 2) General autophagy throughout the cell.298 Cell Host & Microbe 6, October 22, 2009 ª2009 Elsevier Inc.
